Shareholding disclosure

NGN Capital LLC

Declared position

Threshold

Crossed upwards

Timeline

Published

22.08.2014

Transaction

14.08.2014

Voting rights breakdown

Voting rights acquired3%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAE8L00016

Beneficial owner

NGN Capital LLC

Declared address

NGN Capital LLC, New York, NY 10017

NGN BioMed Opportunity I, LP, NGN BioMed Opportunity I GmbH & Co. Beteiligungs KG and NGN BioMed Opportunity, Annex Fund, LP are shareholders in Santhera Pharmaceuticals Holding AG.

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

NGN Capital LLC

Santhera Pharmaceuticals Holding AG22.08.2014TAE8L00016

Disclosure summary

NGN Capital LLC disclosed a holding in Santhera Pharmaceuticals Holding AG on the acquisition side, published by SIX Exchange Regulation on 22.08.2014, at 3% of voting rights. Notice category: Single shareholder.

Disclosed position

Voting rights acquired

Voting rights acquired3%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

NGN Capital LLC disclosed a holding in Santhera Pharmaceuticals Holding AG, published on 22.08.2014.

Publication date22.08.2014

Transaction date14.08.2014

Issuing companySanthera Pharmaceuticals Holding AG

Beneficial ownerNGN Capital LLC

Declared addressNGN Capital LLC, New York, NY 10017

CategorySingle shareholder

Voting rights acquired3%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTAE8L00016

Conditions

NGN BioMed Opportunity I, LP, NGN BioMed Opportunity I GmbH & Co. Beteiligungs KG and NGN BioMed Opportunity, Annex Fund, LP are shareholders in Santhera Pharmaceuticals Holding AG.

Source: SIX Exchange Regulation · Publication date: 22.08.2014

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open